Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,456 | 529 | 99.6% |
| Education | $41.98 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,727 | 104 | $0 (2024) |
| Amgen Inc. | $1,322 | 55 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,179 | 48 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $800.53 | 43 | $0 (2022) |
| Novo Nordisk Inc | $610.24 | 28 | $0 (2024) |
| ABBVIE INC. | $552.70 | 28 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $510.39 | 33 | $0 (2023) |
| Lilly USA, LLC | $452.24 | 23 | $0 (2024) |
| Esperion Therapeutics, Inc. | $433.75 | 22 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $379.40 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,380 | 70 | ABBVIE INC. ($277.03) |
| 2023 | $1,290 | 59 | GlaxoSmithKline, LLC. ($297.68) |
| 2022 | $1,606 | 74 | Novo Nordisk Inc ($300.16) |
| 2021 | $1,501 | 73 | PFIZER INC. ($239.52) |
| 2020 | $1,046 | 58 | GlaxoSmithKline, LLC. ($288.05) |
| 2019 | $1,320 | 68 | PFIZER INC. ($353.01) |
| 2018 | $1,270 | 61 | Janssen Pharmaceuticals, Inc ($273.53) |
| 2017 | $1,085 | 70 | PFIZER INC. ($437.66) |
All Payment Transactions
533 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: Bone Health | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $2.61 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $9.90 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/23/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: VACCINES | ||||||
| 10/16/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Respiratory | ||||||
| 10/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Cardiology | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $14.92 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 09/18/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/17/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Cardiology | ||||||
| 09/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 46 | 4,250 | 7,891 | $874,732 | $384,526 |
| 2022 | 56 | 4,827 | 9,112 | $961,814 | $442,365 |
| 2021 | 55 | 5,369 | 10,024 | $1.0M | $481,638 |
| 2020 | 58 | 5,578 | 10,239 | $1.0M | $466,848 |
All Medicare Procedures & Services
215 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 275 | 808 | $161,600 | $69,634 | 43.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 271 | 1,022 | $152,760 | $65,294 | 42.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 316 | 417 | $125,050 | $56,627 | 45.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 279 | 465 | $81,300 | $44,143 | 54.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 115 | 769 | $57,675 | $35,345 | 61.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 240 | 273 | $54,600 | $25,351 | 46.4% |
| 82652 | Dihydroxyvitamin d, 1, 25 level | Office | 2023 | 191 | 342 | $34,200 | $12,904 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 145 | $21,750 | $8,217 | 37.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 51 | 51 | $10,200 | $6,615 | 64.9% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 55 | 93 | $9,300 | $5,612 | 60.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 190 | 324 | $12,960 | $5,319 | 41.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 35 | $7,875 | $4,661 | 59.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 58 | 60 | $7,170 | $4,306 | 60.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 199 | 412 | $30,900 | $4,244 | 13.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 18 | 19 | $6,650 | $4,035 | 60.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 184 | 295 | $11,635 | $3,861 | 33.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 191 | 348 | $13,920 | $2,642 | 19.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 176 | 297 | $11,880 | $2,625 | 22.1% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 123 | 167 | $6,680 | $2,468 | 37.0% |
| 82746 | Folic acid level, serum | Office | 2023 | 121 | 163 | $6,520 | $2,349 | 36.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 66 | 68 | $3,060 | $2,125 | 69.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 19 | 19 | $2,375 | $1,567 | 66.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 33 | $3,300 | $1,345 | 40.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $2,400 | $1,272 | 53.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 62 | 135 | $4,655 | $1,263 | 27.1% |
About Dr. Nicolas Marsheh, M.D
Dr. Nicolas Marsheh, M.D is a Internal Medicine healthcare provider based in Sterling Heights, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962423657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicolas Marsheh, M.D has received a total of $10,498 in payments from pharmaceutical and medical device companies, with $1,380 received in 2024. These payments were reported across 533 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($10,456).
As a Medicare-enrolled provider, Marsheh has provided services to 20,024 Medicare beneficiaries, totaling 37,266 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 215 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Sterling Heights, MI
- Active Since 07/21/2006
- Last Updated 04/21/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962423657
Products in Payments
- XARELTO (Drug) $705.45
- TRELEGY ELLIPTA (Drug) $700.12
- ELIQUIS (Drug) $649.19
- Otezla (Drug) $505.28
- ENTRESTO (Drug) $493.23
- VRAYLAR (Drug) $440.22
- Repatha (Biological) $375.14
- CHANTIX (Drug) $337.27
- LYRICA (Drug) $331.60
- Ozempic (Drug) $322.97
- NEXLETOL (Drug) $313.70
- Aimovig (Biological) $276.56
- Vascepa (Drug) $232.60
- Rybelsus (Drug) $217.36
- COLOGUARD (Device) $203.23
- Cologuard Collection Kit (Device) $199.74
- MOUNJARO (Drug) $184.38
- ANORO ELLIPTA (Drug) $161.12
- AJOVY (Biological) $152.63
- TOUJEO (Drug) $141.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sterling Heights
Dr. Syed Ali Muttaqi Husain, M.d, M.D
Internal Medicine — Payments: $54,045
Sandeep Garg, Md, MD
Internal Medicine — Payments: $37,573
Dr. Sami Asmar, M.d, M.D
Internal Medicine — Payments: $13,662
Dr. Zbigniew Purzycki, M.d, M.D
Internal Medicine — Payments: $12,572
Dr. Victor Al-Matchy, M.d, M.D
Internal Medicine — Payments: $12,259
Mazen Alsaqa, M.d, M.D
Internal Medicine — Payments: $9,495